The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of X-82, an oral dual anti-VEGFR/PDGFR tyrosine kinase inhibitor, with everolimus in solid tumors.
 
Benjamin R. Tan
Consulting or Advisory Role - Roche/Genentech
Research Funding - Bayer; Eisai; Exelixis; Lilly; Merck Serono; Pfizer; Roche/Genentech; Xcovery
 
Joel Picus
Consulting or Advisory Role - Novo Nordisk
Research Funding - Agensys; Altor BioScience; Astex Pharmaceuticals; BioClin Therapeutics; Mirati Therapeutics; Novartis; Oncogenex
 
Emily Chan
Consulting or Advisory Role - Amgen; Bayer; Castle Biosciences; EMD Serono; Lilly; Taiho Pharmaceutical
Speakers' Bureau - EMD Serono
Research Funding - Aduro Biotech; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Dekkun Corporation; Halozyme; Karyopharm Therapeutics; Merrimack; Millennium; Taiho Pharmaceutical
 
Albert C. Lockhart
Research Funding - Amgen (Inst); Bayer (Inst); CTI (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Teva (Inst); Vertex (Inst); Zenyaku Kogyo (Inst)
 
Bruce J. Roth
No Relationships to Disclose
 
Ashley Morton
No Relationships to Disclose
 
Chris Liang
Employment - Tyrogenex; Xcovery
Leadership - Tyrogenex; Xcovery
Stock and Other Ownership Interests - Tyrogenex; Xcovery
 
Andrea Wang-Gillam
Honoraria - Merrimack; Pfizer
Consulting or Advisory Role - Merrimack; pfizer
Research Funding - Aduro Biotech (Inst); AstraZeneca (Inst); CTI (Inst); EMD Serono (Inst); Halozyme (Inst); Merrimack (Inst); Newlink Genetics (Inst); OncoMed (Inst); pfizer (Inst); Precision Therapeutics (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - Axis Pharma